TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -3 | -7 | -24 | -24 | -58 | -62 | -30 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/14 13:32 | 3/28/14 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Family LP | TX | T | S | -1 | 3.05 | 0 | 0 | 0 | 10,963 | D | 114 | -11 | -4 | 3 | -7 | -12 | 1 | 0 | -4 | -9 | -30 | -31 | -60 | -65 | |
3/27/14 16:10 | 3/25/14 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Family LP | TX | T | S.m | -21 | 3.07 | 0 | -7 | 0 | 10,963 | D | 147 | -5 | 3 | 5 | -4 | -13 | 3 | 7 | -3 | -8 | -32 | -26 | -57 | -64 | |
3/17/14 16:10 | 3/13/14 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Family LP | TX | T | S.m | -25 | 3.11 | 0 | -8 | 0 | 10,970 | D | 121 | -13 | 3 | 4 | -17 | -4 | -14 | -1 | -1 | -4 | -14 | -17 | -53 | -54 | |
3/13/14 16:05 | 3/11/14 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Family LP | TX | T | S.m | -28 | 3.12 | 0 | -9 | 0 | 10,978 | D | 122 | -22 | 0 | 2 | -10 | -6 | -20 | -7 | -3 | -7 | -18 | -22 | -61 | -66 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |